Herantis Pharma Oyj HRPMF

Set alert

Price alert · HRPMF

All alert types
3.51 +3.51 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
59.47M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
—
High
—

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for HRPMF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-41.16 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -14.1×
FY 2015: -1.5×FY 2016: -5.8×FY 2017: -10.3×FY 2018: -7.2×FY 2019: -4.0×FY 2020: -5.9×FY 2021: -1.4×FY 2022: -5.1×FY 2023: 195×FY 2024: -14.1×
FY 2015 5y median -5.1× FY 2024
P/S 0.0×
FY 2015: 12666×FY 2016: 1021×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2015 5y median 0.0× FY 2024
P/B -281×
FY 2015: 4.1×FY 2016: 16.4×FY 2017: 5.4×FY 2018: -336×FY 2019: 17.5×FY 2020: 6.7×FY 2021: 56.8×FY 2022: -797×FY 2023: 11.6×FY 2024: -281×
FY 2015 5y median 6.7× FY 2024
P/FCF -10.4×
FY 2015: -3.3×FY 2016: -8.5×FY 2017: -8.5×FY 2018: -8.0×FY 2019: -5.4×FY 2020: -6.0×FY 2021: -3.2×FY 2022: -5.4×FY 2023: -11.8×FY 2024: -10.4×
FY 2015 5y median -6.0× FY 2024
EV/EBITDA 732×
FY 2015: -4.9×FY 2016: -10.6×FY 2017: -44.8×FY 2018: -12.2×FY 2019: -5.5×FY 2020: -6.4×FY 2021: -4.8×FY 2022: -6.1×FY 2023: 59.1×FY 2024: 732×
FY 2015 5y median -4.8× FY 2024
EV/Sales 0.0×
FY 2015: 16340×FY 2016: 1311×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2015 5y median 0.0× FY 2024
FCF Yield -9.6%
FY 2015: -29.9%FY 2016: -11.8%FY 2017: -11.8%FY 2018: -12.4%FY 2019: -18.4%FY 2020: -16.7%FY 2021: -31.5%FY 2022: -18.6%FY 2023: -8.5%FY 2024: -9.6%
FY 2015 5y median -16.7% FY 2024

Profitability

Gross Margin 0.0%
FY 2015: -576266.0%FY 2016: -7.1%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2015: -826905.4%FY 2016: -17477.3%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2015: -820716.1%FY 2016: -17494.4%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024
ROE 2032.5%
FY 2015: -267.4%FY 2016: -280.9%FY 2017: -52.9%FY 2018: 4681.5%FY 2019: -432.5%FY 2020: -120.6%FY 2021: -4253.3%FY 2022: 15467.0%FY 2023: 5.9%FY 2024: 2032.5%
FY 2015 5y median 5.9% FY 2024
ROIC -258.8%
FY 2015: -117.8%FY 2016: -45.6%FY 2017: -21.0%FY 2018: -77.4%FY 2019: -79.0%FY 2020: -54.6%FY 2021: -172.5%FY 2022: -178.4%FY 2023: 3.2%FY 2024: -258.8%
FY 2015 5y median -172.5% FY 2024
ROA -192.1%
FY 2015: -113.9%FY 2016: -43.4%FY 2017: -18.7%FY 2018: -58.5%FY 2019: -72.3%FY 2020: -55.7%FY 2021: -340.8%FY 2022: -149.6%FY 2023: 4.1%FY 2024: -192.1%
FY 2015 5y median -149.6% FY 2024

Growth (YoY)

Revenue 0.0%
FY 2015: 144.4%FY 2016: 1193.7%FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 FY 2024
Operating Income -3355.9%
FY 2015: -111.1%FY 2016: 72.7%FY 2017: 49.3%FY 2018: -117.3%FY 2019: -46.9%FY 2020: -12.8%FY 2021: -12.1%FY 2022: 11.7%FY 2023: 101.9%FY 2024: -3355.9%
FY 2015 FY 2024
EPS (diluted) -1572.4%
FY 2015: -23.0%FY 2016: 72.8%FY 2017: 50.0%FY 2018: -66.7%FY 2019: -52.9%FY 2020: 9.2%FY 2021: -86.4%FY 2022: 70.9%FY 2023: 102.5%FY 2024: -1572.4%
FY 2015 FY 2024
Free Cash Flow -41.2%
FY 2015: -69.3%FY 2016: 58.9%FY 2017: 14.7%FY 2018: -43.6%FY 2019: -59.6%FY 2020: -43.7%FY 2021: -16.0%FY 2022: 10.0%FY 2023: 48.2%FY 2024: -41.2%
FY 2015 FY 2024

Financial Health

Current Ratio 4.1×
FY 2015: 9.8×FY 2016: 4.7×FY 2017: 3.8×FY 2018: 1.7×FY 2019: 3.6×FY 2020: 4.7×FY 2021: 3.6×FY 2022: 3.3×FY 2023: 3.4×FY 2024: 4.1×
FY 2015 5y median 3.6× FY 2024
Quick Ratio 4.1×
FY 2015: 9.8×FY 2016: 4.7×FY 2017: 3.8×FY 2018: 1.7×FY 2019: 3.6×FY 2020: 4.7×FY 2021: 3.6×FY 2022: 3.3×FY 2023: 3.4×FY 2024: 4.1×
FY 2015 5y median 3.6× FY 2024
Debt / Equity -0.1×
FY 2015: 1.3×FY 2016: 5.2×FY 2017: 1.6×FY 2018: -71.5×FY 2019: 3.9×FY 2020: 0.9×FY 2021: 8.5×FY 2022: -75.3×FY 2023: 0.0×FY 2024: -0.1×
FY 2015 5y median 0.0× FY 2024
Net Debt / EBITDA -6.5×
FY 2015: -1.1×FY 2016: -2.3×FY 2017: -10.2×FY 2018: -1.9×FY 2019: -0.2×FY 2020: 0.7×FY 2021: 0.1×FY 2022: 0.1×FY 2023: -6.6×FY 2024: -6.5×
FY 2015 5y median 0.1× FY 2024
Interest Coverage -888×
FY 2015: -192×FY 2016: -53.6×FY 2017: -7.2×FY 2018: -80.3×FY 2019: -8.2×FY 2020: -7.5×FY 2021: -144×FY 2022: -6.0×FY 2023: 0.3×FY 2024: -888×
FY 2015 5y median -7.5× FY 2024

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31